How much money did Cerebral lose?

Cerebral raised $300M before shutting down in 2024, at a peak valuation of $4.8B. Backers included SoftBank, Access Industries, WestCap. Investors did not recover this capital when the company wound down.

When was Cerebral founded and when did it shut down?

Cerebral was founded in 2020 and ceased operating in 2024, a lifespan of 4 years. The terminal event was 2024: Founder charged with fraud, massive downsizing. The company operated in the Healthcare/Telehealth sector from USA.

What were the contributing factors behind the Cerebral collapse?

Beyond the root cause (A combination of demand-side, execution, and capital-market pressures that this record documents without isolating a single dominant driver.), the analysis identifies 4 contributing factors: Overprescription; DEA Investigation; Founder Fraud; Regulatory Scrutiny. These are interpretation, not verified fact, and are kept separate from the documented timeline.

What can founders learn from Cerebral?

Telehealth ADHD prescribing at scale attracted DEA scrutiny and a DOJ investigation for potential controlled substance fraud. In IdeaProof's failure database of 1,000+ documented shutdowns, overprescription Scandal & DOJ Investigation is a recurring pattern rather than an isolated event — which is why it is testable before you build.

What is the IdeaProof failure score for Cerebral?

Cerebral scores 82/100 on IdeaProof's failure score, a weighted composite of market fit (65/100), burn discipline (80/100) and founder/execution risk (85/100). Higher scores indicate a more severe, more avoidable failure.

Failed 2024

Cerebral

Telehealth ADHD prescribing at scale attracted DEA scrutiny and a DOJ investigation for potential controlled substance fraud.

TL;DR — Failure Post-Mortem

Cerebral was a Healthcare/Telehealth startup founded in 2020 in USA. It raised $300M before collapsing in 2024 — 4 years of runway burned. IdeaProof's AI Failure Score: 82/100, driven by overprescription scandal & doj investigation. The shutdown affected employees, investors, and the broader Healthcare/Telehealth ecosystem. This case study breaks down the timeline, root causes, competitors that won, and replicable lessons for founders validating similar ideas today.

Why did Cerebral fail?

Cerebral failed in 2024 after 4 years of operation, losing $300M in raised capital. The root cause was overprescription scandal & doj investigation. Key lesson: Telehealth ADHD prescribing at scale attracted DEA scrutiny and a DOJ investigation for potential controlled substance fraud.

Verifiable facts

Sourced

Founded → Closed

2020 → 2024

Funding Raised

$300M

Industry

Healthcare/Telehealth

Country

USA

IdeaProof AI Failure Score

82/100

Market Fit Risk

Burn Rate Risk

Founder Risk

What Happened: The Timeline

🚀

2020

Cerebral founded for online mental health treatment

📈

2022

Reaches $4.8B valuation, 4,500 employees

⚠️

2022

Reports of over-prescribing stimulants, DEA investigation

💀

2024

Founder charged with fraud, massive downsizing

Root Causes

Cerebral was a telehealth startup specializing in mental health, particularly ADHD and anxiety. The company grew explosively during COVID, reaching a $4.8B valuation. But reports emerged that Cerebral was aggressively prescribing controlled substances (Adderall, Xanax) with minimal evaluation. The DEA and DOJ launched investigations. CVS and Walmart stopped filling Cerebral prescriptions. The company downsized dramatically and founder Kyle Robertson was charged with fraud in 2024.

Causal Chain

Derived · heuristic

This is our reading of the causal chain — separated from the verifiable facts above. Timeline dates, funding numbers and filings are facts (see methodology); root / proximate / terminal attribution is judgement based on public evidence.

Root cause

A combination of demand-side, execution, and capital-market pressures that this record documents without isolating a single dominant driver.

Contributing factors

Overprescription
DEA Investigation
Founder Fraud
Regulatory Scrutiny

Proximate cause

2022: Reports of over-prescribing stimulants, DEA investigation

Terminal event

2024: Founder charged with fraud, massive downsizing

Base rates

External sources

A single failure is an anecdote. These base rates give you the denominator — how common this outcome is across all startups matching Cerebral's profile. Sources are third-party; we do not restate them as our own claims.

~70%

industry

of digital-health startups fail to reach breakeven; reimbursement complexity + regulatory approvals extend runway needs beyond typical VC horizons.

Rock Health State of Digital Health (2023)

~90%

all

of startups ultimately fail — including ~10% that fail in the first year and the rest across the following decade.

Startup Genome / CB Insights aggregate (2024)

~35%

all

of new US employer businesses survive past their 10th year (Bureau of Labor Statistics BED series).

US Bureau of Labor Statistics — BED (2024)

~35%

stage

of Series A rounds ever graduate to Series B; the rest run out of runway or pivot without a follow-on.

CB Insights Venture Capital Funnel (2023)

Frequently Asked Questions

Sources & Confidence

Every data point is tagged with its source type and our confidence in it. How we grade sources.

Additional references

Wall Street Journal

Could This Failure Have Been Prevented?

IdeaProof's AI validates market demand, competitive positioning, and business model viability in minutes — catching the exact issues that sank Cerebral.

Spotted a factual error?

Approved corrections are published in the public changelog with attribution.

After Cerebral: hubs, comparisons and deep dives

Compare the validation, funding and go-to-market choices that separate survivors from failures like Cerebral.

Start from the hub

Compare your options

Go deeper